Patienter, der tidligere har haft fotoallergi eller fototoksicitetsreaktioner ved behandling med fibrater.
The risk of interaction with other medicinal products (esp. with those products metabolised through CYP2C9 and CYP2C8) was further emphasised in the harmonised SPC.